12962_2016_Article_57.pdf 1006,55KB
1000 Titel
  • Mothers’ willingness to pay for HPV vaccines in Anambra state, Nigeria: A cross sectional contingent valuation study
1000 Autor/in
  1. Umeh, Ifeoma Blessing |
  2. Nduka, Sunday Odunke |
  3. Ekwunife, Obinna |
1000 Erscheinungsjahr 2016
1000 Art der Datei
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2016-06-06
1000 Erschienen in
1000 Quellenangabe
  • 14:8
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2016
1000 Lizenz
1000 Verlagsversion
  • |
  • |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Human papilloma virus (HPV) vaccination in Nigeria will require substantial financing due to high cost of HPV vaccine and inexistence of structures to support adolescent vaccination. Alternative sources are needed to sustain the government funded HPV vaccination programme. This study assessed Nigerian mothers’ willingness-to-pay (WTP) for HPV vaccine. We also compared the difference between the average WTP and estimated costs of vaccinating a pre-adolescent girl (CVG). METHODS: We conducted a quantitative, cross-sectional, survey-based study in which 50 questionnaires were distributed to each of 10 secondary schools located in two rural and one urban city in Anambra state. The questionnaires were then randomly distributed to girls aged 9–12 years of age to give to their mothers. Contingent valuation approach using the payment card technique was used to estimate the average maximum WTP among the survey participants. Correlates of WTP for HPV vaccination were obtained using multivariate logistic regression. Estimated CVG was obtained by adapting cost of HPV vaccine delivery in Tanzania to the Nigerian setting. RESULTS: A total of 438 questionnaires (88 %) were returned. The average WTP was US$ 11.68. This is opposed to estimated delivery cost of US$ 18.16 and US$ 19.26 for urban and rural populations respectively at vaccine price offered by the Vaccine Alliance (Gavi) and US$ 35.16 and US$ 36.26 for urban and rural populations respectively at the lowest obtainable public sector vaccine price. Demand for HPV vaccine was deemed high (91.6 %) and was significantly associated with respondents previously diagnosed of HPV infection. CONCLUSION: Demand for HPV vaccine was high although short of estimated CVG. High demand for vaccine should be capitalized upon to increase vaccine uptake. Education on cervical cancer and provider-initiated vaccination should be promoted to increase vaccine uptake. Co-payment could be a feasible financing strategy in the event of national HPV vaccination.
1000 Sacherschließung
lokal papilloma virus vaccine
lokal patient preference
lokal uterine cervical neoplasms
lokal willingness-to-pay
lokal Nigeria
1000 Fachgruppe
  1. Medizin |
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
1000 Förderer
  1. Alexander von Humboldt Foundation (AVH) |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. research fellowship to study cost-effectiveness of HPV vaccine in Nigeria
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Alexander von Humboldt Foundation (AVH) |
    1000 Förderprogramm research fellowship to study cost-effectiveness of HPV vaccine in Nigeria
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6403958.rdf
1000 Erstellt am 2017-08-17T13:53:13.234+0200
1000 Erstellt von 122
1000 beschreibt frl:6403958
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet Tue Nov 27 14:32:36 CET 2018
1000 Objekt bearb. Tue Nov 27 14:32:36 CET 2018
1000 Vgl. frl:6403958
1000 Oai Id
  1. |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source